Stockscreener 앱 받기
3.27
9.00%
0.27
시간 외 거래:
3.28
0.010
+0.31%
전일 마감가:
$3.00
열려 있는:
$3.08
하루 거래량:
43,336
Relative Volume:
0.82
시가총액:
$4.87M
수익:
$59.11M
순이익/손실:
$-33.38M
주가수익비율:
-0.0183
EPS:
-178.995
순현금흐름:
$-26.04M
1주 성능:
+4.14%
1개월 성능:
-2.39%
6개월 성능:
-80.61%
1년 성능:
-88.92%
1일 변동 폭
$2.98
$3.28
1주일 범위
$2.87
$3.61
52주 변동 폭
$2.5211
$38.52
소님 테크놀로지스 Stock (SONM) Company Profile
명칭
Dna X Inc
전화
650-378-8100
주소
4445 EASTGATE MALL, SAN DIEGO, TX
Compare SONM vs MSFT, ORCL, PLTR, CRWD, SNPS
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
3.27 | 4.46M | 59.11M | -33.38M | -26.04M | -179.00 |
MSFT
Microsoft Corp
|
418.07 | 3.14T | 305.45B | 119.26B | 77.41B | 15.98 |
ORCL
Oracle Corp
|
177.58 | 503.48B | 64.08B | 16.40B | -24.74B | 5.5698 |
PLTR
Palantir Technologies Inc
|
145.89 | 350.12B | 4.48B | 1.63B | 2.10B | 0.6328 |
CRWD
Crowdstrike Holdings Inc
|
433.15 | 107.52B | 4.81B | -181.85M | 1.24B | -0.7398 |
SNPS
Synopsys Inc
|
460.95 | 86.12B | 8.00B | 1.10B | 2.28B | 6.4708 |
소님 테크놀로지스 Stock (SONM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-10-31 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2019-07-18 | 개시 | B. Riley FBR | Buy |
| 2019-07-09 | 업그레이드 | National Securities | Neutral → Buy |
| 2019-06-10 | 개시 | National Securities | Neutral |
| 2019-06-04 | 개시 | Lake Street | Buy |
| 2019-06-04 | 개시 | Oppenheimer | Outperform |
모두보기
소님 테크놀로지스 주식(SONM)의 최신 뉴스
Sonim Technologies Public Entity Rebrands As DNA X, Inc., A Digital Asset Management Company - 富途牛牛
12 Information Technology Stocks Moving In Wednesday's After-Market Session - Benzinga
DNA X, Inc. Reports 2025 Financial Results, Completes Asset Sale, and Focuses on Growth of Cryptocurrency Trading Platform - Minichart
DNA X (NASDAQ: SONM) outlines crypto shift, tiny scale and going‑concern risk - Stock Titan
Global Experts Face-to-Face Interview Series – Redefining Yunnan’s Strategic Value - businessnewsthisweek.com
DNA X, Inc. Reports Full Year 2025 Financial Results - The Globe and Mail
DNA X sold its phone business for $15M to focus on crypto trading - Stock Titan
DNA X Reports $0 Revenue, Nearly $8 Million Loss After Crypto Pivot - TradeKaizen
Earnings Report: Will Applied DNA Sciences Inc outperform its industry peersTrade Entry Report & Smart Allocation Stock Reports - baoquankhu1.vn
SONM Stock Price, Quote & Chart | DNA X INC (NASDAQ:SONM) - ChartMill
Restriction-enzyme DNA fingerprinting method explained - Britannica
NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test - The Manila Times
DNA X : News Release - marketscreener.com
Non-controlling/minority interest of DNA X, Inc. – MUN:J6P - TradingView
Power DNA x Lain: Okori enerugî (Music Video 2017)News - IMDb
How DNA's Double Helix Structure Was Discovered - Britannica
DNA X, Inc. delays 2025 annual filing - The Globe and Mail
Dna X Inc. Live Share Prices and Trades. SONM.US Live Streaming Share Prices. - London South East
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session - Benzinga
[NT 10-K] DNA X, Inc. SEC Filing - Stock Titan
Ansa Biotechnologies Appoints Matthias Arenskötter as Chief Operating Officer - Business Wire
12 Information Technology Stocks Moving In Monday's Intraday SessionAmplitech Group, Inc.Series A R - Benzinga
Feel Good Inc. X DNA. (Mashup) [1e740c] - Fathom Journal
DNA X (SONM) Surges 21.9% on Intraday Spike—What’s Behind the Volatility? - Bitget
The latest Star Wars Zero Company details tease Mass Effect DNA, hardcore turn-based tactics, permadeath, and new Clone Wars lore - Eurogamer.net
SONM Forecast, Price Target & Analyst Ratings | DNA X INC (NASDAQ:SONM) - ChartMill
New liquid biopsy from VolitionRx finds 49 of 49 cancers in early study - Stock Titan
Dna Holdings Venture Inc. Net Worth (2026) - GuruFocus
Illumina Inc.: Why This DNA Giant Just Got Way More Interesting for You - AD HOC NEWS
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 earnings call transcript - MSN
Equity in earnings of DNA X, Inc. – MUN:J6P - TradingView
Hitachi's DNA on Display at Its Birthplace Why the Company's Origin Park Matters as It Globalizes - 東洋経済オンライン
DNA Brands, Inc. (DNAX) Competitors - Meyka
SONM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2025 Earnings Call Transcript - insidermonkey.com
DNA X (NASDAQ: SONM) revises view of DNA X LLC acquisition - Stock Titan
DNA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
How do XX and XY Chromosomes Determine Biological Sex? - Britannica
SONM SEC FilingsDNA X 10-K, 10-Q, 8-K Forms - Stock Titan
Acurx Pharmaceuticals (ACXP) Secures New US Patent for DNA Polymerase IIIC Inhibitors - Yahoo Finance Singapore
Major SONM holder DNA Holdings Venture reports 223,201 shares - Stock Titan
DNA Holdings takes 19.99% stake in DNA X, Inc. (SONM) with board rights - Stock Titan
Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation - Stock Titan
cGAS-IFN-I responses by extracting nuclear DNA from dying cells via nucleocytosis - Nature
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Feb. 13 Policy Watch: Bipartisan bills target DNA bioweapons, battery supply chain - Chemical & Engineering News
Leadership and Strategy Shift at DNA X Following Core Business Divestment - AD HOC NEWS
Sonim Technologies Names Mike Mulica Acting Chief Executive - TipRanks
DNA X, Inc. Appoints Mike Mulica as Acting CEO - TradingView
DNAX stock jumps to $0.0001 on 09 Feb 2026 (PNK): liquidity and valuation in focus - Meyka
Nancy Guthrie’s blood was found on her porch, DNA testing confirms - WBAY
소님 테크놀로지스 (SONM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.29%
자본화:
|
볼륨(24시간):